CXCL10 and head and neck squamous cell carcinoma: In vitro studies have shown that blocking EGFR with antibodies or kinase inhibitors facilitate the secretion of chemokines (CCL2, CCL5, and CXCL10) in HNSCC cells and keratinocytes when IFN and tumor necrosis factor (TNF) are stimulated (46).